stock market trading floor

Markets Close Out July on Mixed Note: Chevron Shines While Big Pharma Stumbles – July 31, 2026

As Wall Street wraps up the final trading day of July 2026, investors are digesting a mixed bag of corporate earnings while keeping a close eye on the artificial intelligence narrative that continues to dominate market sentiment. Friday’s session brings a flurry of quarterly reports, with energy giant Chevron delivering a standout performance even as pharmaceutical heavyweight AbbVie falls short of expectations.

AI Continues to Drive Market Narrative

The week’s biggest story remains Amazon’s massive AI investments, with CEO Andy Jassy successfully calming investor nerves about the company’s aggressive spending in the artificial intelligence space. According to today’s headlines, Jassy’s reassurance appears to have resonated with the market, underscoring just how central AI has become to corporate strategy and investor confidence.

The AI theme extends beyond the tech giants. Fintech broker Clear Street is now offering investors pre-IPO access to Databricks, the $188 billion AI giant that has become one of the most anticipated public offerings in recent memory. Meanwhile, GM announced plans to launch a new in-vehicle AI system later this year, demonstrating how artificial intelligence is permeating every corner of the economy.

Microsoft shares are also surging on continued AI optimism, with market strategist Mike Khouw suggesting there’s still money to be made in the software giant despite its impressive run.

Earnings Scorecard: Winners and Losers

Friday’s earnings reports paint a picture of an economy with pockets of strength and weakness. Here’s how the key players performed:

Notable Beats

  • Chevron (CVX) delivered the day’s biggest surprise, posting EPS of $6.06 versus expectations of $5.615 – a convincing beat that signals resilience in the energy sector despite volatile commodity prices.
  • Carter’s (CRI) crushed expectations with EPS of $0.26 against estimates of just $0.06, suggesting the children’s apparel retailer may be finding its footing after a challenging period.
  • Colgate-Palmolive (CL) edged past forecasts with EPS of $0.99 versus $0.98 expected, continuing its streak of steady consumer staples performance.
  • Franklin Resources (BEN) posted EPS of $0.72, beating the $0.68 estimate and providing a bright spot for asset managers.
  • Cboe Global Markets (CBOE) reported EPS of $3.56, narrowly topping the $3.55 consensus and reflecting healthy trading activity.
  • Arbor Realty Trust (ABR) nearly doubled expectations with EPS of $0.10 versus $0.05 estimated.

Disappointing Misses

  • AbbVie (ABBV) fell just short with EPS of $3.65 against estimates of $3.68, a minor miss but one that may concern investors watching the pharmaceutical giant’s post-Humira transition.
  • Cameco (CCJ) significantly underperformed, reporting EPS of $0.18 versus expectations of $0.38 – a miss that could raise questions about uranium market dynamics.
  • AngloGold Ashanti (AU) disappointed with EPS of $1.98 versus the $2.25 estimate, despite gold prices remaining elevated.
  • AutoNation (AN) narrowly missed with EPS of $5.56 against $5.66 expected, reflecting ongoing normalization in the auto retail space.
  • Church & Dwight (CHD) came in light at $0.89 versus $0.91 expected.

Beyond the Numbers

The entertainment sector is providing some welcome positive news, with ‘Spider-Man: Brand New Day’ setting a domestic box office preview record at $72 million. The blockbuster opening suggests consumer appetite for premium entertainment experiences remains robust, a positive signal for the broader discretionary spending environment.

In sports business news, FIFA is testing new boundaries by exploring a World Cup subsidiary sale to private equity, highlighting the continued institutionalization of sports assets as an alternative investment class.

Technical Picture and Outlook

According to market technicians, the S&P 500 finds itself “stuck at a key battleground level,” with analysts pointing to an obscure index that could determine the market’s next directional move. This technical stalemate comes as July draws to a close, with investors weighing strong AI-driven momentum against mixed fundamental signals from corporate earnings.

As we head into August, market participants will be watching closely for signs of whether the AI investment boom can continue to justify elevated valuations, or if concerns about spending returns will begin to weigh more heavily on sentiment. For now, the bulls appear to maintain the upper hand, but the narrow margin of safety suggested by today’s mixed earnings reports warrants continued vigilance.

Stay tuned for Monday’s market briefing as we kick off a new month of trading.


Posted

in

by

Comments

Leave a Reply

Discover more from Money Fad

Subscribe now to keep reading and get access to the full archive.

Continue reading